How much is the Oncology Drugs market?

The oncology drugs market size is estimated to grow at $$ 215.9 bn in 2024. Read More

What is the growth rate of the Oncology Drugs market?

The growth rate of the oncology drugs year-over-year is 13.4%. Read More

Which region held the largest market share in the Oncology Drugs market?

North America is the region to held the largest market share with 45% growth. Read More

Who are the key players in the Oncology Drugs market?

AbbVie Inc., Amgen Inc., Apikos Pharma, Arlak Biotech Pvt. Ltd., Aspen Pharmacare Holdings Ltd., Astellas Pharma Inc., AstraZeneca Plc, Athenex Inc., Bayer AG, Bristol Myers .... Read More

Which Segment has the largest market share in the Oncology Drugs market?

Therapy is the segment that has the largest market share in the market. Read More

Oncology Drugs Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, Italy, The Netherlands, UK), Asia, and Rest of World (ROW)

Published: Mar 2025
Pages: 222
SKU: IRTNTR75604

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Form Factor
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2024

4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Oncology Drugs Market 2019 - 2023
- Historic Market Size - Data Table on Global Oncology Drugs Market 2019 - 2023 ($ billion)

5.2 Therapy segment analysis 2019 - 2023
- Historic Market Size - Therapy Segment 2019 - 2023 ($ billion)

5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)

5.4 Form Factor segment analysis 2019 - 2023
- Historic Market Size - Form Factor Segment 2019 - 2023 ($ billion)

5.5 Indication segment analysis 2019 - 2023
- Historic Market Size - Indication Segment 2019 - 2023 ($ billion)

5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)

5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 Impact of AI on the Global Oncology Drugs Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029

7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Therapy

8.1 Market segments
- Chart on Therapy - Market share 2024-2029 (%)
- Data Table on Therapy - Market share 2024-2029 (%)

8.2 Comparison by Therapy
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy

8.3 Targeted therapy - Market size and forecast 2024-2029
- Chart on Targeted therapy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Targeted therapy - Market size and forecast 2024-2029 ($ billion)
- Chart on Targeted therapy - Year-over-year growth 2024-2029 (%)
- Data Table on Targeted therapy - Year-over-year growth 2024-2029 (%)

8.4 Immunotherapy and hormonal therapy - Market size and forecast 2024-2029
- Chart on Immunotherapy and hormonal therapy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2024-2029 ($ billion)
- Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2024-2029 (%)
- Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2024-2029 (%)

8.5 Chemotherapy - Market size and forecast 2024-2029
- Chart on Chemotherapy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ billion)
- Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
- Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)

8.6 Market opportunity by Therapy
- Market opportunity by Therapy ($ billion)
- Data Table on Market opportunity by Therapy ($ billion)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)

9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel

9.3 Offline - Market size and forecast 2024-2029
- Chart on Offline - Market size and forecast 2024-2029 ($ billion)
- Data Table on Offline - Market size and forecast 2024-2029 ($ billion)
- Chart on Offline - Year-over-year growth 2024-2029 (%)
- Data Table on Offline - Year-over-year growth 2024-2029 (%)

9.4 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ billion)
- Data Table on Online - Market size and forecast 2024-2029 ($ billion)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)

9.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ billion)
- Data Table on Market opportunity by Distribution Channel ($ billion)

10 Market Segmentation by Form Factor

10.1 Market segments
- Chart on Form Factor - Market share 2024-2029 (%)
- Data Table on Form Factor - Market share 2024-2029 (%)

10.2 Comparison by Form Factor
- Chart on Comparison by Form Factor
- Data Table on Comparison by Form Factor

10.3 Solid - Market size and forecast 2024-2029
- Chart on Solid - Market size and forecast 2024-2029 ($ billion)
- Data Table on Solid - Market size and forecast 2024-2029 ($ billion)
- Chart on Solid - Year-over-year growth 2024-2029 (%)
- Data Table on Solid - Year-over-year growth 2024-2029 (%)

10.4 Liquid - Market size and forecast 2024-2029
- Chart on Liquid - Market size and forecast 2024-2029 ($ billion)
- Data Table on Liquid - Market size and forecast 2024-2029 ($ billion)
- Chart on Liquid - Year-over-year growth 2024-2029 (%)
- Data Table on Liquid - Year-over-year growth 2024-2029 (%)

10.5 Injectable - Market size and forecast 2024-2029
- Chart on Injectable - Market size and forecast 2024-2029 ($ billion)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ billion)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)

10.6 Market opportunity by Form Factor
- Market opportunity by Form Factor ($ billion)
- Data Table on Market opportunity by Form Factor ($ billion)

11 Market Segmentation by Indication

11.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)

11.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication

11.3 Lung cancer - Market size and forecast 2024-2029
- Chart on Lung cancer - Market size and forecast 2024-2029 ($ billion)
- Data Table on Lung cancer - Market size and forecast 2024-2029 ($ billion)
- Chart on Lung cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Lung cancer - Year-over-year growth 2024-2029 (%)

11.4 Colorectal cancer - Market size and forecast 2024-2029
- Chart on Colorectal cancer - Market size and forecast 2024-2029 ($ billion)
- Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ billion)
- Chart on Colorectal cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%)

11.5 Stomach cancer - Market size and forecast 2024-2029
- Chart on Stomach cancer - Market size and forecast 2024-2029 ($ billion)
- Data Table on Stomach cancer - Market size and forecast 2024-2029 ($ billion)
- Chart on Stomach cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Stomach cancer - Year-over-year growth 2024-2029 (%)

11.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)

11.7 Market opportunity by Indication
- Market opportunity by Indication ($ billion)
- Data Table on Market opportunity by Indication ($ billion)

12 Customer Landscape

12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

13.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)

13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)

13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)

13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)

13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)

13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)

13.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)

13.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)

13.10 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)

13.11 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)

13.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)

13.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)

13.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)

13.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)

13.16 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)

13.17 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)

14 Drivers, Challenges, and Opportunity/Restraints

14.1 Market drivers

14.2 Market challenges

14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

14.4 Market opportunities/restraints

15 Competitive Landscape

15.1 Overview

15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

15.3 Landscape disruption
- Overview on factors of disruption

15.4 Industry risks
- Impact of key risks on business

16 Competitive Analysis

16.1 Companies profiled
- Companies covered

16.2 Company ranking index
- Company ranking index

16.3 Market positioning of companies
- Matrix on companies position and classification

16.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT

16.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT

16.6 Aspen Pharmacare Holdings Ltd.
- Aspen Pharmacare Holdings Ltd. - Overview
- Aspen Pharmacare Holdings Ltd. - Business segments
- Aspen Pharmacare Holdings Ltd. - Key offerings
- Aspen Pharmacare Holdings Ltd. - Segment focus
- SWOT

16.7 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT

16.8 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT

16.9 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT

16.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT

16.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT

16.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT

16.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT

16.14 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT

16.15 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT

16.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT

16.17 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT

16.18 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

17 Appendix